Narsoplimab
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances.
Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances.
Journal: Frontiers in pharmacology
Published: March 20, 2026
New Anticomplement Drugs in Nephrology: Mechanism and Indication.
Journal: Kidney & blood pressure research
Published: November 28, 2025
Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care.
Journal: Blood advances
Published: June 23, 2025
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA).
Journal: American journal of hematology
Published: May 30, 2025
Targeting the Roots of Kidney Disease: Systematic Review of the Therapies Targeting the Complement System.
Journal: Medicina (Kaunas, Lithuania)
Published: March 24, 2025
Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT).
Journal: Bone marrow transplantation
Published: January 17, 2025
Translating biomarker insights into practice: a path forward in TA-TMA management.
Journal: Frontiers in medicine
Published: December 23, 2024
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
Journal: Bone marrow transplantation
Published: February 27, 2024
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Journal: Transplantation and cellular therapy
Published: November 18, 2023
Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus.
Journal: Bone marrow transplantation
Published: October 24, 2023
Last Updated: 09/26/2026